Hispidin analogue davallialactone attenuates carbon tetrachloride-induced hepatotoxicity in mice. 2012

Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
Laboratory of Liver Regeneration, Research Institute of Clinical Medicine of Chonbuk National University, Chonbuk National University Hospital, Jeonju 561-712, Korea.

In this study the protective effects of davallialactone (1), isolated from Inonotus xeranticus, have been examined against carbon tetrachloride (CCl₄-induced acute liver injury. Mice received subcutaneous injection of 1 (2.5, 5, and 10 mg/kg) for three days before CCl₄ injection (1 mg/kg). Protection from liver injury by 1 was confirmed by the observation of decreased serum transaminases and diminished necrosis of liver tissue. Reduced hepatic injury was very similar to that observed with silymarin, a known hepatoprotective drug used in this work for comparison. The groups treated with 1 had reduced reactive oxygen species (ROS), reduced serum malonyldialdehyde levels, and increased levels of liver Cu/Zn superoxide dismutase, as compared to the CCl₄ control group. The expression of heme oxygenase-1 in the liver tissue was increased and the activity of liver cytochrome P4502E1 was restored in the mice treated with 1. In addition, levels of serum tumor necrosis factor-alpha (TNF-α), inducible NO synthase (iNOS), and cyclooxygenase-2 (COX-2), numbers of macrophage, and cleaved caspase-3-positive hepatocytes were reduced in the groups treated with 1. These findings suggest that davallialactone has protective effects against CCl₄-induced acute liver injury, and this protection is likely due to the suppression of ROS-induced lipid peroxidation and inflammatory response.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011753 Pyrones Keto-pyrans.
D002251 Carbon Tetrachloride A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) Tetrachloromethane,Tetrachloride, Carbon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
May 1969, Toxicology and applied pharmacology,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
December 2009, Basic & clinical pharmacology & toxicology,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
January 2023, Drug and chemical toxicology,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
January 2021, Combinatorial chemistry & high throughput screening,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
March 2020, Antioxidants (Basel, Switzerland),
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
December 2012, European journal of clinical investigation,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
June 2016, Heliyon,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
December 2003, Journal of pharmacological sciences,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
November 1994, The Journal of pharmacology and experimental therapeutics,
Prabodh Risal, and Pyoung Han Hwang, and Bong Sik Yun, and Ho-Keun Yi, and Baik Hwan Cho, and Kyu Yun Jang, and Yeon Jun Jeong
June 2010, Toxicology,
Copied contents to your clipboard!